Skip to content

A feasibility study of 1-mm bolus for postmastectomy radiotherapy

A feasibility study of 1-mm bolus for postmastectomy radiotherapy - 1-mm bolus for postmastectomy radiotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000035773
Enrollment
20
Registered
2019-07-01
Start date
2019-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

None listed

Sponsors

Juntendo University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients who meet all of the following criteria; 1. Aged 20 years and older 2. Received mastectomy, pathologically confirmed breast cancer, and needed to receive postmastectomy radiotherapy 3. Performance status (ECOG) 0-2 4. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Patients have other concomitant active malignancy except carcinoma in situ. 2. Patients have uncontrolled diabetes. 3. Patients have active interstitial pneumonitis or lung fibrosis or advanced pulmonary emphysema. 4. Patients have active collagen disease. 5. Patients have heart failure, myocardial infarction or angina pectoris within 6 months. 6. Patients have pregnancy or nursing. 7. Patients have psychiatric disorders that may comprise the patient's ability to receive radiotherapy. 8. Patients have breast reconstruction before radiotherapy 9. Patients have prior overlapping radiation. 10. Patients who need to receive boost irradiation for positive surgical margin. 11.Patients who is considered ineligible for enrolling the study by a principal investigator or sub-investigator.

Design outcomes

Primary

MeasureTime frame
Skin toxicity from start of radiotherapy to 12 weeks after completion of radiotherapy

Secondary

MeasureTime frame
1. Chest wall recurrences during observation 2. Skin dose using dosimeters within 5 times of beginning radiation

Countries

Japan

Contacts

Public ContactTerufumi Kawamoto

Juntendo University Department of Radiation Oncology

t-kawamoto@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026